 Makoto Miyazaki
Concepts (562)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stearoyl-CoA Desaturase | 42 | 2015 | 65 | 4.560 |
Why?
| | Vascular Calcification | 9 | 2022 | 111 | 4.000 |
Why?
| | Renal Insufficiency, Chronic | 9 | 2024 | 626 | 2.280 |
Why?
| | Endoplasmic Reticulum | 6 | 2025 | 262 | 1.760 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 9 | 2018 | 207 | 1.680 |
Why?
| | Atherosclerosis | 8 | 2021 | 402 | 1.620 |
Why?
| | Activating Transcription Factor 4 | 5 | 2021 | 21 | 1.610 |
Why?
| | Transcription Factor CHOP | 4 | 2018 | 32 | 1.500 |
Why?
| | Bile Acids and Salts | 3 | 2018 | 156 | 1.400 |
Why?
| | Autophagy | 6 | 2025 | 283 | 1.360 |
Why?
| | Fatty Acids | 19 | 2018 | 446 | 1.210 |
Why?
| | Liver | 21 | 2019 | 1821 | 1.180 |
Why?
| | Endoplasmic Reticulum Stress | 4 | 2021 | 111 | 1.130 |
Why?
| | Calcinosis | 4 | 2014 | 238 | 1.020 |
Why?
| | Membrane Proteins | 4 | 2025 | 1144 | 1.000 |
Why?
| | Mice | 73 | 2025 | 17969 | 0.990 |
Why?
| | Lipids | 12 | 2022 | 686 | 0.960 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2018 | 216 | 0.870 |
Why?
| | Adverse Drug Reaction Reporting Systems | 3 | 2021 | 80 | 0.850 |
Why?
| | Animals | 82 | 2025 | 37328 | 0.780 |
Why?
| | Deoxycholic Acid | 3 | 2022 | 17 | 0.760 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 15 | 0.740 |
Why?
| | Kidney | 10 | 2025 | 1482 | 0.740 |
Why?
| | Stearic Acids | 2 | 2012 | 16 | 0.730 |
Why?
| | Leptin | 9 | 2010 | 238 | 0.720 |
Why?
| | Mice, Knockout | 29 | 2025 | 3042 | 0.710 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2025 | 465 | 0.660 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2018 | 258 | 0.640 |
Why?
| | Vascular Diseases | 2 | 2014 | 244 | 0.620 |
Why?
| | Vascular Stiffness | 1 | 2024 | 450 | 0.610 |
Why?
| | Starvation | 1 | 2019 | 23 | 0.600 |
Why?
| | Isoenzymes | 6 | 2006 | 296 | 0.590 |
Why?
| | Autistic Disorder | 1 | 2022 | 211 | 0.590 |
Why?
| | Cyclin T | 1 | 2018 | 2 | 0.580 |
Why?
| | Lipid Metabolism | 15 | 2018 | 522 | 0.580 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2018 | 18 | 0.580 |
Why?
| | Mice, Inbred C57BL | 25 | 2025 | 5866 | 0.530 |
Why?
| | Kidney Diseases | 4 | 2019 | 409 | 0.520 |
Why?
| | Apolipoproteins E | 4 | 2014 | 91 | 0.510 |
Why?
| | Coronary Vessels | 2 | 2022 | 246 | 0.500 |
Why?
| | eIF-2 Kinase | 2 | 2013 | 31 | 0.500 |
Why?
| | Cholesterol | 8 | 2016 | 404 | 0.490 |
Why?
| | Autism Spectrum Disorder | 1 | 2022 | 418 | 0.490 |
Why?
| | Lipogenesis | 4 | 2012 | 64 | 0.490 |
Why?
| | Vaccines | 1 | 2021 | 407 | 0.470 |
Why?
| | Phosphatidylethanolamines | 1 | 2015 | 75 | 0.460 |
Why?
| | Triglycerides | 11 | 2014 | 510 | 0.450 |
Why?
| | Coronary Artery Disease | 2 | 2022 | 716 | 0.450 |
Why?
| | Fatty Acid Desaturases | 2 | 2006 | 31 | 0.420 |
Why?
| | Osteogenesis | 4 | 2021 | 199 | 0.420 |
Why?
| | Polycystic Kidney Diseases | 2 | 2025 | 73 | 0.410 |
Why?
| | Signal Transduction | 15 | 2024 | 5116 | 0.410 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 5 | 2020 | 37 | 0.400 |
Why?
| | Blood Vessels | 2 | 2011 | 173 | 0.390 |
Why?
| | Dietary Fats | 5 | 2007 | 303 | 0.390 |
Why?
| | Disease Models, Animal | 14 | 2025 | 4414 | 0.390 |
Why?
| | Metabolomics | 1 | 2018 | 702 | 0.380 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2025 | 428 | 0.370 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 3 | 2019 | 31 | 0.370 |
Why?
| | Japan | 6 | 2021 | 134 | 0.360 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2024 | 445 | 0.350 |
Why?
| | Cells, Cultured | 12 | 2019 | 4149 | 0.340 |
Why?
| | Cisplatin | 3 | 2020 | 328 | 0.340 |
Why?
| | Transcription Factors | 6 | 2006 | 1706 | 0.330 |
Why?
| | Pharmacovigilance | 2 | 2021 | 24 | 0.330 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2600 | 0.320 |
Why?
| | Fatty Liver | 3 | 2012 | 237 | 0.320 |
Why?
| | DNA-Binding Proteins | 7 | 2008 | 1483 | 0.300 |
Why?
| | Acute Kidney Injury | 3 | 2025 | 822 | 0.300 |
Why?
| | Phosphorylation | 9 | 2018 | 1753 | 0.300 |
Why?
| | Humans | 47 | 2025 | 141284 | 0.290 |
Why?
| | Fukushima Nuclear Accident | 2 | 2020 | 2 | 0.290 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 9 | 2011 | 56 | 0.290 |
Why?
| | Mice, Transgenic | 7 | 2018 | 2165 | 0.280 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 2091 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1220 | 0.280 |
Why?
| | Inflammation | 6 | 2021 | 2840 | 0.280 |
Why?
| | Protein Isoforms | 5 | 2019 | 397 | 0.280 |
Why?
| | Male | 41 | 2025 | 70140 | 0.280 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 2 | 2024 | 266 | 0.270 |
Why?
| | Adiposity | 3 | 2010 | 520 | 0.270 |
Why?
| | Orphan Nuclear Receptors | 5 | 2012 | 14 | 0.270 |
Why?
| | Macrophages | 6 | 2021 | 1478 | 0.270 |
Why?
| | Oleic Acid | 4 | 2009 | 42 | 0.270 |
Why?
| | Mice, Inbred DBA | 2 | 2018 | 198 | 0.270 |
Why?
| | Myocardium | 4 | 2010 | 911 | 0.250 |
Why?
| | Cell Proliferation | 4 | 2024 | 2502 | 0.250 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 195 | 0.250 |
Why?
| | Obesity | 8 | 2010 | 3007 | 0.240 |
Why?
| | Receptors, LDL | 2 | 2018 | 51 | 0.240 |
Why?
| | Insulin Resistance | 3 | 2009 | 1221 | 0.230 |
Why?
| | Transcription, Genetic | 4 | 2020 | 1486 | 0.230 |
Why?
| | Epithelial Cells | 4 | 2019 | 1105 | 0.230 |
Why?
| | Fructokinases | 2 | 2016 | 35 | 0.230 |
Why?
| | Lymphoid Tissue | 1 | 2025 | 80 | 0.220 |
Why?
| | Tetraspanins | 2 | 2014 | 19 | 0.220 |
Why?
| | Uric Acid | 2 | 2024 | 163 | 0.220 |
Why?
| | Salmonella Infections | 1 | 2025 | 56 | 0.220 |
Why?
| | Deoxyglucose | 1 | 2024 | 49 | 0.210 |
Why?
| | Urate Oxidase | 1 | 2024 | 11 | 0.210 |
Why?
| | Adipose Tissue | 4 | 2010 | 645 | 0.210 |
Why?
| | Glomerulonephritis | 2 | 2021 | 45 | 0.210 |
Why?
| | Cell Line | 5 | 2018 | 2863 | 0.210 |
Why?
| | Energy Metabolism | 3 | 2008 | 926 | 0.200 |
Why?
| | Diet | 4 | 2021 | 1277 | 0.200 |
Why?
| | Fructose | 1 | 2004 | 117 | 0.200 |
Why?
| | Salmonella typhimurium | 1 | 2025 | 189 | 0.200 |
Why?
| | Liver X Receptors | 5 | 2012 | 30 | 0.200 |
Why?
| | Fibroblasts | 2 | 2021 | 1018 | 0.200 |
Why?
| | Sebaceous Glands | 1 | 2002 | 5 | 0.200 |
Why?
| | Kidney Tubules, Proximal | 2 | 2022 | 128 | 0.200 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2005 | 97 | 0.190 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2012 | 269 | 0.190 |
Why?
| | Isothiocyanates | 1 | 2022 | 4 | 0.190 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2022 | 7 | 0.190 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2022 | 9 | 0.190 |
Why?
| | Lysosomes | 2 | 2021 | 129 | 0.180 |
Why?
| | Biomarkers | 5 | 2025 | 4180 | 0.180 |
Why?
| | Integrin alpha5 | 1 | 2021 | 2 | 0.180 |
Why?
| | Folate Receptor 2 | 1 | 2021 | 8 | 0.180 |
Why?
| | Multienzyme Complexes | 4 | 2005 | 66 | 0.180 |
Why?
| | Calibration | 1 | 2022 | 151 | 0.180 |
Why?
| | Parathyroid Hormone | 1 | 2022 | 111 | 0.180 |
Why?
| | Dyslipidemias | 2 | 2022 | 177 | 0.180 |
Why?
| | Judgment | 1 | 2022 | 65 | 0.170 |
Why?
| | Phosphates | 1 | 2022 | 178 | 0.170 |
Why?
| | Chernobyl Nuclear Accident | 1 | 2020 | 5 | 0.170 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.170 |
Why?
| | Kidney Glomerulus | 2 | 2019 | 121 | 0.170 |
Why?
| | Fibroblast Growth Factors | 1 | 2022 | 185 | 0.170 |
Why?
| | Anticholesteremic Agents | 2 | 2012 | 153 | 0.170 |
Why?
| | Spectrum Analysis, Raman | 2 | 2011 | 42 | 0.170 |
Why?
| | Skin | 1 | 2005 | 760 | 0.160 |
Why?
| | Podocytes | 2 | 2019 | 69 | 0.160 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2020 | 8 | 0.160 |
Why?
| | Homeostasis | 2 | 2021 | 632 | 0.160 |
Why?
| | Amino Acid Sequence | 3 | 2019 | 2146 | 0.160 |
Why?
| | Tissue Distribution | 3 | 2007 | 325 | 0.160 |
Why?
| | Stomach Neoplasms | 1 | 2021 | 118 | 0.160 |
Why?
| | NF-kappa B | 1 | 2024 | 684 | 0.160 |
Why?
| | Gene Knockout Techniques | 2 | 2018 | 117 | 0.160 |
Why?
| | Down-Regulation | 4 | 2008 | 636 | 0.160 |
Why?
| | Bayes Theorem | 1 | 2022 | 414 | 0.160 |
Why?
| | Cattle | 3 | 2011 | 982 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 130 | 0.150 |
Why?
| | Hepatocytes | 2 | 2019 | 217 | 0.150 |
Why?
| | HeLa Cells | 5 | 2025 | 642 | 0.150 |
Why?
| | Tretinoin | 1 | 2020 | 121 | 0.150 |
Why?
| | Insulin | 7 | 2009 | 2472 | 0.150 |
Why?
| | Fatty Acids, Monounsaturated | 4 | 2009 | 54 | 0.150 |
Why?
| | Kidney Failure, Chronic | 1 | 2025 | 599 | 0.150 |
Why?
| | Amino Acids | 2 | 2021 | 491 | 0.150 |
Why?
| | Blotting, Northern | 6 | 2005 | 199 | 0.150 |
Why?
| | Mitochondria, Liver | 2 | 2012 | 70 | 0.150 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2022 | 263 | 0.150 |
Why?
| | Intestine, Small | 1 | 2020 | 157 | 0.150 |
Why?
| | Heat-Shock Response | 1 | 2019 | 77 | 0.140 |
Why?
| | Sepsis | 1 | 2025 | 627 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2021 | 170 | 0.140 |
Why?
| | Bacterial Proteins | 1 | 2025 | 913 | 0.140 |
Why?
| | Receptors, Fc | 1 | 2019 | 54 | 0.140 |
Why?
| | Carrier Proteins | 2 | 2021 | 738 | 0.140 |
Why?
| | Osteopontin | 1 | 2018 | 31 | 0.140 |
Why?
| | Serum Albumin | 1 | 2019 | 148 | 0.140 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2018 | 70 | 0.140 |
Why?
| | TRPP Cation Channels | 3 | 2024 | 81 | 0.140 |
Why?
| | Rats | 6 | 2024 | 5556 | 0.140 |
Why?
| | Fever | 1 | 2019 | 310 | 0.140 |
Why?
| | Quality Assurance, Health Care | 1 | 2020 | 319 | 0.140 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 254 | 0.130 |
Why?
| | Dietary Carbohydrates | 3 | 2007 | 151 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2019 | 143 | 0.130 |
Why?
| | Interleukin-33 | 1 | 2017 | 50 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 207 | 0.130 |
Why?
| | Disease Progression | 3 | 2021 | 2808 | 0.130 |
Why?
| | Adaptive Immunity | 1 | 2018 | 170 | 0.130 |
Why?
| | Databases, Factual | 2 | 2020 | 1449 | 0.130 |
Why?
| | Gene Knockdown Techniques | 3 | 2014 | 331 | 0.130 |
Why?
| | Chelating Agents | 1 | 2017 | 73 | 0.130 |
Why?
| | Ion Pumps | 1 | 2016 | 1 | 0.130 |
Why?
| | Phosphorus | 1 | 2017 | 98 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 858 | 0.130 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 71 | 0.130 |
Why?
| | Hypertriglyceridemia | 3 | 2008 | 39 | 0.130 |
Why?
| | Mice, Mutant Strains | 4 | 2012 | 305 | 0.130 |
Why?
| | Adipocytes, White | 2 | 2022 | 19 | 0.120 |
Why?
| | Heart | 4 | 2010 | 616 | 0.120 |
Why?
| | Female | 25 | 2025 | 75814 | 0.120 |
Why?
| | Base Sequence | 4 | 2007 | 2170 | 0.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 436 | 0.120 |
Why?
| | Cell Differentiation | 4 | 2012 | 1983 | 0.120 |
Why?
| | Muscle, Smooth | 1 | 2016 | 150 | 0.120 |
Why?
| | Diet, Fat-Restricted | 2 | 2006 | 77 | 0.120 |
Why?
| | Mitochondria | 3 | 2019 | 962 | 0.120 |
Why?
| | Carbohydrate Metabolism | 2 | 2007 | 61 | 0.120 |
Why?
| | Radiation Monitoring | 1 | 2015 | 15 | 0.120 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2016 | 199 | 0.110 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 452 | 0.110 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1761 | 0.110 |
Why?
| | Albuminuria | 1 | 2016 | 185 | 0.110 |
Why?
| | Radiometry | 1 | 2015 | 54 | 0.110 |
Why?
| | Gamma Rays | 1 | 2015 | 56 | 0.110 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1244 | 0.110 |
Why?
| | Hydrocarbons, Fluorinated | 2 | 2012 | 8 | 0.110 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 628 | 0.110 |
Why?
| | Protein Binding | 3 | 2018 | 2233 | 0.110 |
Why?
| | Lung Neoplasms | 3 | 2020 | 2554 | 0.110 |
Why?
| | Metabolic Syndrome | 3 | 2008 | 352 | 0.110 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2019 | 882 | 0.110 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2014 | 50 | 0.110 |
Why?
| | Osteoblasts | 2 | 2012 | 136 | 0.110 |
Why?
| | Bone Marrow | 1 | 2016 | 298 | 0.110 |
Why?
| | Ezetimibe | 1 | 2014 | 25 | 0.110 |
Why?
| | Azetidines | 1 | 2014 | 46 | 0.110 |
Why?
| | Simvastatin | 1 | 2014 | 62 | 0.110 |
Why?
| | DNA Damage | 1 | 2017 | 430 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 918 | 0.100 |
Why?
| | Body Weight | 7 | 2010 | 992 | 0.100 |
Why?
| | Dehydration | 1 | 2013 | 54 | 0.100 |
Why?
| | Bone Density | 1 | 2017 | 496 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1973 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1250 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 716 | 0.100 |
Why?
| | Cholesterol Ester Transfer Proteins | 1 | 2012 | 19 | 0.100 |
Why?
| | Benzoates | 1 | 2012 | 49 | 0.090 |
Why?
| | Muscle, Skeletal | 5 | 2005 | 1747 | 0.090 |
Why?
| | Isoxazoles | 1 | 2012 | 54 | 0.090 |
Why?
| | Catechin | 1 | 2012 | 25 | 0.090 |
Why?
| | Lipoproteins, HDL | 1 | 2012 | 78 | 0.090 |
Why?
| | Nicorandil | 1 | 2012 | 11 | 0.090 |
Why?
| | Middle Aged | 7 | 2025 | 34658 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 911 | 0.090 |
Why?
| | Nitric Oxide Donors | 1 | 2012 | 21 | 0.090 |
Why?
| | Minerals | 1 | 2012 | 44 | 0.090 |
Why?
| | DNA Primers | 3 | 2007 | 507 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2017 | 3577 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 684 | 0.090 |
Why?
| | Oxidation-Reduction | 5 | 2010 | 1080 | 0.090 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 94 | 0.090 |
Why?
| | RNA, Messenger | 7 | 2018 | 2815 | 0.090 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2011 | 32 | 0.090 |
Why?
| | Antioxidants | 2 | 2012 | 593 | 0.090 |
Why?
| | Molecular Imaging | 1 | 2011 | 55 | 0.090 |
Why?
| | Mice, Nude | 3 | 2021 | 700 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1043 | 0.090 |
Why?
| | Aorta | 2 | 2012 | 423 | 0.090 |
Why?
| | Models, Biological | 5 | 2006 | 1810 | 0.080 |
Why?
| | Glucose | 2 | 2007 | 1027 | 0.080 |
Why?
| | Etoposide | 1 | 2011 | 163 | 0.080 |
Why?
| | Plaque, Atherosclerotic | 1 | 2011 | 58 | 0.080 |
Why?
| | Risk Factors | 3 | 2022 | 10490 | 0.080 |
Why?
| | Sulfonamides | 2 | 2012 | 576 | 0.080 |
Why?
| | Alkaline Phosphatase | 1 | 2011 | 144 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2012 | 196 | 0.080 |
Why?
| | Chenodeoxycholic Acid | 1 | 2010 | 12 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 605 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3345 | 0.080 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 2162 | 0.080 |
Why?
| | Mice, Obese | 3 | 2006 | 65 | 0.080 |
Why?
| | Diacylglycerol O-Acyltransferase | 2 | 2006 | 5 | 0.080 |
Why?
| | Aged | 5 | 2025 | 24836 | 0.080 |
Why?
| | Cell Movement | 1 | 2014 | 962 | 0.080 |
Why?
| | Aging | 2 | 2019 | 1919 | 0.080 |
Why?
| | Agouti Signaling Protein | 1 | 2009 | 2 | 0.080 |
Why?
| | Cholic Acids | 1 | 2008 | 13 | 0.070 |
Why?
| | Gene Silencing | 2 | 2016 | 198 | 0.070 |
Why?
| | Hypercholesterolemia | 2 | 2006 | 101 | 0.070 |
Why?
| | Mutation | 6 | 2018 | 4006 | 0.070 |
Why?
| | Microscopy | 1 | 2010 | 156 | 0.070 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 293 | 0.070 |
Why?
| | Ceramides | 2 | 2010 | 117 | 0.070 |
Why?
| | Hyperlipidemia, Familial Combined | 1 | 2008 | 3 | 0.070 |
Why?
| | Transgenes | 2 | 2006 | 185 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2008 | 131 | 0.070 |
Why?
| | Receptor, Insulin | 2 | 2006 | 94 | 0.070 |
Why?
| | Blotting, Western | 6 | 2007 | 1220 | 0.070 |
Why?
| | Lipocalin-2 | 2 | 2020 | 79 | 0.070 |
Why?
| | Acyltransferases | 2 | 2005 | 75 | 0.070 |
Why?
| | Microsomes | 2 | 2007 | 33 | 0.070 |
Why?
| | Glycogen | 2 | 2004 | 54 | 0.070 |
Why?
| | Mycological Typing Techniques | 1 | 2007 | 1 | 0.070 |
Why?
| | Tumor Burden | 2 | 2020 | 314 | 0.070 |
Why?
| | Histoplasma | 1 | 2007 | 9 | 0.070 |
Why?
| | Gluconeogenesis | 1 | 2007 | 78 | 0.070 |
Why?
| | Histoplasmosis | 1 | 2007 | 15 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2009 | 367 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2529 | 0.070 |
Why?
| | Adipose Tissue, Brown | 2 | 2004 | 56 | 0.070 |
Why?
| | Time Factors | 4 | 2019 | 6951 | 0.070 |
Why?
| | Animal Feed | 2 | 2004 | 53 | 0.070 |
Why?
| | Sucrose | 1 | 2007 | 111 | 0.070 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2017 | 528 | 0.060 |
Why?
| | Pedigree | 1 | 2008 | 506 | 0.060 |
Why?
| | Blood Pressure | 4 | 2016 | 1740 | 0.060 |
Why?
| | Health Surveys | 2 | 2021 | 511 | 0.060 |
Why?
| | Mice, SCID | 2 | 2004 | 367 | 0.060 |
Why?
| | Child | 3 | 2021 | 22390 | 0.060 |
Why?
| | Lipolysis | 2 | 2022 | 46 | 0.060 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2025 | 13 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2006 | 2911 | 0.060 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2005 | 3 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Carnitine O-Palmitoyltransferase | 4 | 2007 | 48 | 0.060 |
Why?
| | Colitis | 1 | 2008 | 263 | 0.060 |
Why?
| | Receptors, Retinoic Acid | 2 | 2020 | 41 | 0.060 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2004 | 2 | 0.050 |
Why?
| | Oxypurinol | 1 | 2024 | 3 | 0.050 |
Why?
| | Structure-Activity Relationship | 2 | 2018 | 569 | 0.050 |
Why?
| | Oxonic Acid | 1 | 2024 | 8 | 0.050 |
Why?
| | Up-Regulation | 2 | 2004 | 851 | 0.050 |
Why?
| | Lipodystrophy | 1 | 2004 | 13 | 0.050 |
Why?
| | Thermogenesis | 1 | 2004 | 46 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2004 | 43 | 0.050 |
Why?
| | Xanthine Oxidase | 1 | 2024 | 81 | 0.050 |
Why?
| | Chronic Disease | 1 | 2010 | 1807 | 0.050 |
Why?
| | Hypothermia | 1 | 2004 | 48 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2024 | 2511 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2904 | 0.050 |
Why?
| | Cholestasis | 1 | 2006 | 214 | 0.050 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2003 | 14 | 0.050 |
Why?
| | Transfection | 2 | 2021 | 932 | 0.050 |
Why?
| | Anti-Obesity Agents | 1 | 2004 | 59 | 0.050 |
Why?
| | Body Temperature Regulation | 1 | 2004 | 102 | 0.050 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 111 | 0.050 |
Why?
| | Foam Cells | 2 | 2016 | 17 | 0.050 |
Why?
| | Cell Membrane | 2 | 2005 | 704 | 0.050 |
Why?
| | Chromatography, Gas | 1 | 2002 | 32 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2005 | 866 | 0.050 |
Why?
| | Cholesterol, Dietary | 1 | 2002 | 15 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 274 | 0.050 |
Why?
| | Cold Temperature | 1 | 2004 | 196 | 0.050 |
Why?
| | Neoplasm Invasiveness | 2 | 2014 | 510 | 0.050 |
Why?
| | Inflammasomes | 1 | 2024 | 143 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 389 | 0.050 |
Why?
| | Cytokines | 2 | 2024 | 2079 | 0.050 |
Why?
| | Sulfoxides | 1 | 2022 | 4 | 0.050 |
Why?
| | Thiazolidines | 1 | 2022 | 10 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 36 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2003 | 167 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2002 | 51 | 0.050 |
Why?
| | Protein Transport | 2 | 2019 | 446 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2003 | 235 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2025 | 369 | 0.040 |
Why?
| | Aminopterin | 1 | 2021 | 3 | 0.040 |
Why?
| | Apoptosis | 3 | 2020 | 2487 | 0.040 |
Why?
| | RNA | 2 | 2007 | 927 | 0.040 |
Why?
| | Hypolipidemic Agents | 1 | 2022 | 93 | 0.040 |
Why?
| | Phospholipids | 1 | 2003 | 211 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 1 | 2006 | 556 | 0.040 |
Why?
| | Autophagosomes | 1 | 2021 | 20 | 0.040 |
Why?
| | Social Conditions | 1 | 2020 | 13 | 0.040 |
Why?
| | Norway | 1 | 2020 | 44 | 0.040 |
Why?
| | Enzyme Activation | 3 | 2011 | 784 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 47 | 0.040 |
Why?
| | Proteinuria | 1 | 2021 | 98 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 587 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 835 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2005 | 873 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5653 | 0.040 |
Why?
| | Biological Assay | 1 | 2021 | 128 | 0.040 |
Why?
| | Adipocytes | 1 | 2002 | 220 | 0.040 |
Why?
| | Hypophosphatemia, Familial | 1 | 2020 | 4 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 54 | 0.040 |
Why?
| | Butadienes | 1 | 2020 | 37 | 0.040 |
Why?
| | Retinoid X Receptors | 1 | 2020 | 38 | 0.040 |
Why?
| | Methotrexate | 1 | 2021 | 255 | 0.040 |
Why?
| | Immunoblotting | 3 | 2005 | 308 | 0.040 |
Why?
| | Folic Acid | 1 | 2021 | 198 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2022 | 267 | 0.040 |
Why?
| | 2,4-Dinitrophenol | 1 | 2019 | 9 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2020 | 148 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 161 | 0.040 |
Why?
| | Kidney Medulla | 1 | 2019 | 31 | 0.040 |
Why?
| | Pyrimidinones | 1 | 2020 | 122 | 0.040 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 630 | 0.040 |
Why?
| | Liver Regeneration | 1 | 2019 | 45 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2019 | 74 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 54 | 0.040 |
Why?
| | Testosterone | 1 | 2002 | 404 | 0.040 |
Why?
| | Nitriles | 1 | 2020 | 189 | 0.040 |
Why?
| | Oxygen | 1 | 2004 | 986 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 541 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 451 | 0.040 |
Why?
| | DNA | 1 | 2005 | 1440 | 0.040 |
Why?
| | Pyridones | 1 | 2020 | 191 | 0.040 |
Why?
| | Fluorocarbons | 2 | 2012 | 132 | 0.030 |
Why?
| | Odds Ratio | 1 | 2021 | 1057 | 0.030 |
Why?
| | Adult | 5 | 2022 | 39319 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2020 | 320 | 0.030 |
Why?
| | Urinary Tract | 1 | 2018 | 51 | 0.030 |
Why?
| | Stem Cells | 1 | 2002 | 604 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2012 | 1059 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 755 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 435 | 0.030 |
Why?
| | Weight Loss | 1 | 2002 | 794 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 3502 | 0.030 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 11 | 0.030 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2018 | 191 | 0.030 |
Why?
| | Dietary Fats, Unsaturated | 2 | 2006 | 24 | 0.030 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 49 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2021 | 7948 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 341 | 0.030 |
Why?
| | Nuclear Power Plants | 1 | 2015 | 3 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 5948 | 0.030 |
Why?
| | Oxidative Stress | 2 | 2012 | 1327 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 822 | 0.030 |
Why?
| | Hyperlipidemias | 1 | 2016 | 126 | 0.030 |
Why?
| | Chemokine CXCL6 | 1 | 2014 | 2 | 0.030 |
Why?
| | Mice, Inbred Strains | 2 | 2006 | 404 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 560 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2016 | 193 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2017 | 364 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 316 | 0.030 |
Why?
| | History, 21st Century | 1 | 2015 | 218 | 0.030 |
Why?
| | Gene Expression | 3 | 2004 | 1490 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 5809 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 491 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2017 | 484 | 0.030 |
Why?
| | Blood Glucose | 4 | 2006 | 2286 | 0.030 |
Why?
| | Fatty Acid Synthases | 2 | 2005 | 23 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2013 | 26 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2809 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2047 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 29 | 0.030 |
Why?
| | Radiation Dosage | 1 | 2015 | 189 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2014 | 103 | 0.030 |
Why?
| | Immunotherapy | 1 | 2018 | 641 | 0.030 |
Why?
| | ras Proteins | 1 | 2014 | 145 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 249 | 0.020 |
Why?
| | Lipoproteins, VLDL | 2 | 2002 | 19 | 0.020 |
Why?
| | Macaca fascicularis | 1 | 2012 | 69 | 0.020 |
Why?
| | Cytochromes c | 1 | 2012 | 59 | 0.020 |
Why?
| | beta Catenin | 1 | 2014 | 256 | 0.020 |
Why?
| | Succinate Dehydrogenase | 1 | 2012 | 52 | 0.020 |
Why?
| | Pregnancy | 1 | 2005 | 7035 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1380 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 213 | 0.020 |
Why?
| | Streptozocin | 1 | 2012 | 21 | 0.020 |
Why?
| | Cholesterol Esters | 1 | 2011 | 7 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1261 | 0.020 |
Why?
| | Bone Matrix | 1 | 2011 | 8 | 0.020 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 34 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 587 | 0.020 |
Why?
| | Biological Transport | 1 | 2012 | 409 | 0.020 |
Why?
| | Serum | 1 | 2011 | 58 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 573 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 384 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 13727 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 501 | 0.020 |
Why?
| | Diet, High-Fat | 1 | 2012 | 253 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 128 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 621 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2012 | 195 | 0.020 |
Why?
| | Epididymis | 1 | 2010 | 13 | 0.020 |
Why?
| | Flow Cytometry | 2 | 2006 | 1182 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2010 | 171 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 89 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 165 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 66 | 0.020 |
Why?
| | Stromal Cells | 1 | 2009 | 117 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 983 | 0.020 |
Why?
| | Feces | 1 | 2012 | 489 | 0.020 |
Why?
| | Oxygen Consumption | 2 | 2002 | 712 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 247 | 0.020 |
Why?
| | ATP Binding Cassette Transporter 1 | 1 | 2008 | 10 | 0.020 |
Why?
| | Adolescent | 2 | 2020 | 22116 | 0.020 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2008 | 14 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 448 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 117 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 21 | 0.020 |
Why?
| | Dextran Sulfate | 1 | 2008 | 84 | 0.020 |
Why?
| | PPAR alpha | 1 | 2007 | 57 | 0.020 |
Why?
| | Sporothrix | 1 | 2007 | 3 | 0.020 |
Why?
| | Paracoccidioides | 1 | 2007 | 2 | 0.020 |
Why?
| | Pigments, Biological | 1 | 2007 | 17 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 2007 | 29 | 0.020 |
Why?
| | Blastomyces | 1 | 2007 | 9 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2008 | 251 | 0.020 |
Why?
| | Collagen | 1 | 2010 | 452 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 68 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 134 | 0.020 |
Why?
| | Lipid Metabolism Disorders | 1 | 2006 | 3 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2007 | 79 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2006 | 16 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2025 | 16447 | 0.020 |
Why?
| | PPAR gamma | 1 | 2008 | 175 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 502 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2006 | 40 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2010 | 513 | 0.020 |
Why?
| | Receptors, Leptin | 1 | 2006 | 25 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 46 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 490 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 112 | 0.020 |
Why?
| | Response Elements | 1 | 2006 | 89 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2006 | 41 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 153 | 0.020 |
Why?
| | Octoxynol | 1 | 2005 | 13 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2006 | 183 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2005 | 18 | 0.010 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 47 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 2006 | 110 | 0.010 |
Why?
| | Acyl-CoA Oxidase | 1 | 2005 | 2 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2010 | 554 | 0.010 |
Why?
| | Ethanolaminephosphotransferase | 1 | 2005 | 1 | 0.010 |
Why?
| | Glycerol-3-Phosphate O-Acyltransferase | 1 | 2005 | 1 | 0.010 |
Why?
| | Microarray Analysis | 1 | 2005 | 117 | 0.010 |
Why?
| | Fish Oils | 1 | 2005 | 26 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2006 | 324 | 0.010 |
Why?
| | Thinness | 1 | 2005 | 96 | 0.010 |
Why?
| | Serine C-Palmitoyltransferase | 1 | 2004 | 8 | 0.010 |
Why?
| | Sphingomyelins | 1 | 2004 | 21 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 2004 | 31 | 0.010 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2004 | 17 | 0.010 |
Why?
| | Serine | 1 | 2005 | 148 | 0.010 |
Why?
| | Glycerol | 1 | 2005 | 90 | 0.010 |
Why?
| | Palmitic Acid | 1 | 2004 | 42 | 0.010 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2006 | 176 | 0.010 |
Why?
| | Catalysis | 1 | 2005 | 320 | 0.010 |
Why?
| | Homozygote | 1 | 2005 | 199 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 368 | 0.010 |
Why?
| | Echocardiography | 1 | 2007 | 647 | 0.010 |
Why?
| | Receptors, Adrenergic, beta-3 | 1 | 2004 | 4 | 0.010 |
Why?
| | Uncoupling Protein 1 | 1 | 2004 | 17 | 0.010 |
Why?
| | Plasmids | 1 | 2005 | 365 | 0.010 |
Why?
| | Cysteine | 1 | 2005 | 208 | 0.010 |
Why?
| | Fats | 1 | 2004 | 18 | 0.010 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2004 | 17 | 0.010 |
Why?
| | Trans-Activators | 1 | 2006 | 395 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 415 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2004 | 158 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2005 | 213 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 816 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 228 | 0.010 |
Why?
| | Ion Channels | 1 | 2004 | 128 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6270 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2003 | 50 | 0.010 |
Why?
| | Glucose Transporter Type 4 | 1 | 2003 | 38 | 0.010 |
Why?
| | Epitopes | 1 | 2005 | 476 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2006 | 672 | 0.010 |
Why?
| | Body Temperature | 1 | 2004 | 224 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 510 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1050 | 0.010 |
Why?
| | Muscles | 1 | 2004 | 331 | 0.010 |
Why?
| | Hydroxymethylglutaryl CoA Reductases | 1 | 2002 | 13 | 0.010 |
Why?
| | Protein Conformation | 1 | 2005 | 939 | 0.010 |
Why?
| | Vacuoles | 1 | 2002 | 39 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2002 | 133 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 2002 | 83 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1362 | 0.010 |
Why?
| | Cell Size | 1 | 2002 | 88 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2002 | 152 | 0.010 |
Why?
| | Gene Dosage | 1 | 2002 | 142 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2004 | 259 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2002 | 432 | 0.010 |
Why?
| | Infant | 1 | 2015 | 9820 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2002 | 757 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11511 | 0.010 |
Why?
| | Eating | 1 | 2002 | 393 | 0.010 |
Why?
| | Phylogeny | 1 | 2004 | 997 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1620 | 0.010 |
Why?
| | Body Mass Index | 1 | 2005 | 2390 | 0.010 |
Why?
|
|
Miyazaki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|